Evidence map›Paper›PMID 28575080›Full record

ArticlePloS one2017

Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.

Marion Desclozeaux, Amy Robbins, Martina Jelocnik, Shahneaz Ali Khan, Jon Hanger, Volker Gerdts, Andrew Potter, Adam Polkinghorne, Peter Timms

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Current status and future directions ofFrontiers in veterinary science · 2026
    Pooled it
  2. Article
  3. Article
  4. Dominance of Vaccine-SpecificEcology and evolution · 2025
    Article
  5. Epidemiology, Transmission Mode, and Pathogenesis ofAnimals : an open access journal from MDPI · 2024
    Review
  6. Article
  7. Article
  8. Frontiers in cell and developmental biology · 2024
    Review
  9. Article
  10. Reduction ofVaccine: X · 2023
    Article
  11. Article
  12. Pathogens (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Microorganisms · 2019
    Review
  19. Seventy Years ofFrontiers in microbiology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Marion DesclozeauxCentre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine coast, Maroochydore DC, Queensland, Australia.ORCID http://orcid.org/0000-0001-7504-9683
Amy RobbinsEndeavour Veterinary Ecology Pty Ltd, Toorbul, Queensland, Australia.
Martina JelocnikCentre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine coast, Maroochydore DC, Queensland, Australia.
Shahneaz Ali KhanCentre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine coast, Maroochydore DC, Queensland, Australia.
Jon HangerEndeavour Veterinary Ecology Pty Ltd, Toorbul, Queensland, Australia.
Volker GerdtsVaccine and Infectious Disease Organization- International Vaccine Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Andrew PotterVaccine and Infectious Disease Organization- International Vaccine Centre, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Adam PolkinghorneCentre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine coast, Maroochydore DC, Queensland, Australia.
Peter TimmsCentre for Animal Health Innovation, Faculty of Science, Health, Education and Engineering, University of the Sunshine coast, Maroochydore DC, Queensland, Australia.
University of the Sunshine Coast · AUReef Ecologic · AUUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We assessed the effects of two different single-dose anti-Chlamydia pecorum (C. pecorum) vaccines (containing either Major Outer Membrane Protein (3MOMP) or Polymorphic Membrane Protein (Pmp) as antigens) on the immune response of a group of wild koalas. Both vaccines elicited a systemic humoral response as seen by the production of anti-chlamydial IgG antibodies in more than 90% of vaccinated koalas. A mucosal immune response was also observed, with an increase in Chlamydia-specific mucosal IgG and/or IgA antibodies in some koalas post-vaccination. Both vaccines elicited a cell-mediated immune response as measured by the production of the cytokines IFN-γ and IL-17 post-vaccination. To determine the level of protection provided by the vaccines under natural conditions we assessed C. pecorum infection loads and chlamydial disease status of all vaccinated koalas pre- and post-vaccination, compared to a non-vaccinated cohort from the same habitat. The MOMP vaccinated koalas that were infected on the day of vaccination showed significant clearance of their infection at 6 months post-vaccination. In contrast, the number of new infections in the PMP vaccine was similar to the control group, with some koalas progressing to disease. Genotyping of the ompA gene from the C. pecorum strains infecting the vaccinated animals, identified genetic variants of ompA-F genotype and a new genotype ompA-O. We found that those animals that were the least well protected became infected with strains of C. pecorum not covered by the vaccine. In conclusion, a single dose vaccine formulated with either recombinant PmpG or MOMP can elicit both cell-mediated and humoral (systemic and mucosal) immune responses, with the MOMP vaccine showing clearance of infection in all infected koalas. Although the capability of our vaccines to stimulate an adaptive response and be protective needs to be fully evaluated, this work illustrates the necessity to combine epitopes most relevant to a large panel of variable strains with an efficient adjuvant.

Indexed as

AnimalsAntibodies, BacterialBacterial Outer Membrane ProteinsBacterial VaccinesChlamydiaChlamydia InfectionsImmunity, MucosalPhascolarctidaeAntibodies, BacterialBacterial Outer Membrane ProteinsBacterial Vaccines

Identifiers

PMID28575080
PMCPMC5456371
OpenAlexW2621081443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.